Journal Mobile Options
Table of Contents
Vol. 4, No. 2, 2011
Issue release date: May – August
Open Access Gateway
Case Rep Oncol 2011;4:343–349
(DOI:10.1159/000330367)
Published: July 2011

Soft Tissue Paraspinal Inflammatory Malignant Fibrous Histiocytoma Presenting as a Lumbar Abscess

Liarmakopoulos E.a · Lampropoulos P.a · Marinis A.a · Markakis C.a · Manoloudaki K.b · Chatzimarkou A.a · Rizos S.a
aFirst Department of Surgery, Departments of bPathology and cRadiology, ‘Tzaneion’ General Hospital, Zanni and Afentouli STR, Piraeus, Greece

Abstract

The rarest subtype of malignant fibrous histiocytoma (MFH) is the inflammatory type, which due to its peculiar clinical presentation may mimic an infectious process such as an abscess. The rarity of this disease and the unique features of its presentation may mislead the surgeon with consequent catastrophic results for the patient. In this study, a case report of a 65-year-old female patient with a soft-tissue inflammatory MFH presenting as a lumbar abscess and a review of the current literature are presented.

 goto top of outline Author Contacts

Pavlos Lampropoulos, MD
13 Mikras Asias Str.
GR–16345 Athens (Greece)
Tel. +30 210 994 9460
E-Mail pav.lampropoulos@gmail.com


 goto top of outline Article Information

Published online: July 9, 2011
Number of Print Pages : 7
Number of Figures : 3,


 goto top of outline Publication Details

Case Reports in Oncology

Vol. 4, No. 2, Year 2011 (Cover Date: May - August)

Journal Editor: Markman M. (Philadelphia, Pa.)
ISSN: NIL (Print), eISSN: 1662-6575 (Online)

For additional information: http://www.karger.com/CRO


Open Access License / Drug Dosage

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.